Markets

Worst Performance YTD: MasterCard, Lazard

Thanks to the GuruFocus All-In-One screener, we selected the worst performing stocks of the year that have solid performances over the past 10 years and guarantee profitability and a solid financial situation.

BP Prudhoe Bay Royalty Trust . ( BPT ) reports a negative performance year-to-date with a price drop of -28.5%.

The company was formed for the purpose of owning and administering the royalty interest.

BP Prudhoe Bay Royalty has a very high ROE of 12,355.39% and ROA of 8,064.77%, which are outperforming 99% of other companies in the global oil and gas refining and marketing industry. Gurufocus gives an overall profitability and growth rating of 5 of 10. The current financial strength is rated 8 of10, with no debt.

Over the past 10 years, the company shows strong ratios. The 10-year median of ROE is 10,133.07%, of ROA is 8,336.21% and even margins are supporting these performances, with an average operating margin of 99.40% and an average net margin of 99.29%.

MasterCard Inc Class A . ( MA ) reports a negative performance year-to-date with a price drop of -1.6%.

It is a technology company in the payments industry that connects consumers, financial institutions, merchants, governments and businesses, enabling them to use electronic forms of payment instead of cash and checks.

MasterCard has a ROE of 61.47% and a ROA of 24.42%, which are outperforming 98% of other companies in the global credit services industry. GuruFocus gives an overall profitability and growth rating of 7 of 10. The current financial strength is rated 8 of 10, with a cash to debt ratio of 1.86.

Over the past 10 years, the company shows strong ratios. The 10-year median of ROE is 42.78%, of ROA is 21.81% and even margins are supporting these performances, with an average operating margin of 53.27% and an average net margin of 31.01%.

Tom Russo ( Trades , Portfolio ) is the largest shareholder among the gurus, with 0.88% of outstanding shares, followed by Spiros Segalas ( Trades , Portfolio ) with 0.8%, Ruane Cunniff ( Trades , Portfolio ) with 0.47%, Steve Mandel ( Trades , Portfolio ) with 0.46%, Warren Buffett ( Trades , Portfolio ) with 0.45%, Chuck Akre ( Trades , Portfolio ) with 0.43% and Manning & Napier Advisors Inc with 0.43%.

United Therapeutics Corp. ( UTHR ) reports a negative performance year-to-date with a price drop of -22.7%.

It is a biotechnology company engaged in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening conditions.

United Therapeutics has a ROE of 65.50% and a ROA of 44.45%, which are outperforming 98% of other companies in the global biotechnology industry. GuruFocus gives an overall profitability and growth rating of 9 of 10. The current financial strength is rated 9 of 10, with a cash to debt ratio of 180.57, well above the industry median of 59.07.

Jim Simons ( Trades , Portfolio ) is the largest shareholder among the gurus, with 1.06%

About GuruFocus: GuruFocus.com tracks the stocks picks and portfolio holdings of the world's best investors. This value investing site offers stock screeners and valuation tools. And publishes daily articles tracking the latest moves of the world's best investors. GuruFocus also provides promising stock ideas in 3 monthly newsletters sent to Premium Members .

This article first appeared on GuruFocus .

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

MANH UTHR MA LAZ CHKR

Other Topics

Stocks